Avitaminosis (Hypovitaminosis) – Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 36
Inquire Before Buying

Avitaminosis (Hypovitaminosis) – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, ‘Avitaminosis (Hypovitaminosis) – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Avitaminosis (Hypovitaminosis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Avitaminosis (Hypovitaminosis). Avitaminosis (Hypovitaminosis) – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Avitaminosis (Hypovitaminosis).
- A review of the Avitaminosis (Hypovitaminosis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Avitaminosis (Hypovitaminosis) pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Avitaminosis (Hypovitaminosis).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Avitaminosis (Hypovitaminosis) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Avitaminosis (Hypovitaminosis) – Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Avitaminosis (Hypovitaminosis) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Avitaminosis (Hypovitaminosis) 7
Avitaminosis (Hypovitaminosis) Therapeutics under Development by Companies 9
Avitaminosis (Hypovitaminosis) Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Avitaminosis (Hypovitaminosis) Therapeutics - Products under Development by Companies 14
Avitaminosis (Hypovitaminosis) Therapeutics - Products under Investigation by Universities/Institutes 15
Companies Involved in Avitaminosis (Hypovitaminosis) Therapeutics Development 16
Kyowa Hakko Kirin Co., Ltd. 16
Zeria Pharmaceutical Co Ltd 17
Emisphere Technologies, Inc. 18
Cytochroma Inc. 19
Avitaminosis (Hypovitaminosis) - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
sodium phosphate - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
CTAP-101 - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
KRN-23 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
cholecalciferol - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Avitaminosis (Hypovitaminosis) Therapeutics - Drug Profile Updates 29
Avitaminosis (Hypovitaminosis) Therapeutics - Dormant Products 32
Avitaminosis (Hypovitaminosis) - Product Development Milestones 33
Featured News & Press Releases 33
Sep 20, 2012: Cytochroma Initiates Phase III Study Of CTAP101 Capsules In Chronic Kidney Disease Patients 33
Nov 02, 2009: Interim Study Data Demonstrate Eligen B12 Oral Formulation Achieves Comparable Results to B12 Injection 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

List of Tables
Number of Products Under Development for Avitaminosis (Hypovitaminosis), H2 2012 7
Products under Development for Avitaminosis (Hypovitaminosis) - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Number of Products under Investigation by Universities/Institutes, H2 2012 10
Comparative Analysis by Late Stage Development, H2 2012 11
Comparative Analysis by Mid Clinical Stage Development, H2 2012 12
Comparative Analysis by Early Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Products under Investigation by Universities/Institutes, H2 2012 15
Kyowa Hakko Kirin Co., Ltd., H2 2012 16
Zeria Pharmaceutical Co Ltd, H2 2012 17
Emisphere Technologies, Inc., H2 2012 18
Cytochroma Inc., H2 2012 19
Assessment by Monotherapy Products, H2 2012 20
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Stage and Molecule Type, H2 2012 24
Avitaminosis (Hypovitaminosis) Therapeutics - Drug Profile Updates 29
Avitaminosis (Hypovitaminosis) Therapeutics - Dormant Products 32

List of Figures
Number of Products under Development for Avitaminosis (Hypovitaminosis), H2 2012 7
Products under Development for Avitaminosis (Hypovitaminosis) - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Products under Investigation by Universities/Institutes, H2 2012 10
Late Stage Products, H2 2012 11
Mid Clinical Stage Products, H2 2012 12
Early Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 20
Assessment by Route of Administration, H2 2012 21
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Molecule Type, H2 2012 23
Assessment by Stage and Molecule Type, H2 2012 24

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Global and China Monoclonal Antibody Industry Report, 2014-2019
    Published: 21-Oct-2014        Price: US $2600 Onwards        Pages: 136
    Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biotech drugs with the fastest CAGR in recent years. Global blockbuster monoclonal antibody agents are still concentrated in Roche (Genentech), Amgen, AbbVie (Abbott), Johnson & Johnson, Novartis, etc. In 2013, the top 10 best-selling monoclonal antibody agents (Humira, Remicade, Enbrel, Rituxa, ......
  • Multinational Pharmaceuticals Companies in Asia Online Database
    Published: 20-Oct-2014        Price: US $1660 Onwards        
    The Multinational Pharmaceuticals Companies in Asia Online Database contains the latest available, individually researched data for 6690 senior executives at 2020 leading American, Asian, European and Middle Eastern & African multinational companies and key local companies in Asia. About the Multinational Pharmaceuticals Companies in Asia Online Database The Multinational Pharmaceuticals Companies in Asia Online Database is a powerful, cost-effective business development and research t......
  • Healthcare/Medical Simulation Market by Product (Patient Simulator, Surgical Simulator, Web-based simulation, Simulation Software, Dental Simulator, Eye Simulator), End-User (Academics, Hospitals, Military) & by Services – Global Forecast to 2019
    Published: 20-Oct-2014        Price: US $4650 Onwards        Pages: 250
    The global healthcare/medical simulation market is expected to grow at a lucrative CAGR of 19.1% during the forecast period of 2014 to 2019. Increasing focus on training of medical practitioners, rising healthcare costs, growing focus on patient safety, consolidation of the manufacturers, and rising demand for minimally invasive technologies are expected to drive the growth of the global healthcare/medical simulation market during the forecast period of 2014 to 2019. Several manufacturers in the......
  • Optical Imaging Market by Technique (Optical Coherence Tomography, Hyperspectral Imaging, Photoacoustic Tomography), Product (Imaging System, Imaging software) & by Application (Ophthalmology, Neurology, Oncology, Cardiology) – Global Forecasts to 2019
    Published: 17-Oct-2014        Price: US $4650 Onwards        Pages: 225
    Over the last decade, the optical imaging market has grown, primarily due to the widening applications of optical imaging techniques, the increased demand for safer and noninvasive imaging modalities, and a rising need to minimize the use of radiation in diagnostic imaging. The fast-growing pharmaceutical and biotechnology industries are also catalyzing the growth of the optical imaging market. In this report, the global optical imaging market is segmented by techniques, products, application......
  • 2014 Deep Research Report on Global Kinesio Tape Industry
    Published: 17-Oct-2014        Price: US $3600 Onwards        Pages: 162
    This is a professional and depth research report on Global Kinesio tape industry. The report firstly introduced Kinesio tape basic information included Kinesio tape definition classification application industry chain structure industry overview; Then introduce North America Europe Asia Rest of World Key players 2009-2014 Kinesio tape Capacity Production Price Cost Gross Production Value Gross Margin etc Data and information. And the report also listed North America Europe Asia Rest of Wor......
  • Orthopaedics: Market Prospects & Global Competition
    Published: 16-Oct-2014        Price: US $1500 Onwards        Pages: 540
    After a period of economic decline, the global orthopaedics market is beginning to show signs of recovery, thanks to a number of factors. It is now time to take stock of the opportunities and challenges that lie ahead. The orthopaedic industry has been under intense pressure since the global economic downturn, and has struggled to achieve growth amid tough market conditions. Additionally, the industry is under extreme pressure to adapt to the impact of social and economic changes. Rising case......
  • Canada Surgical Sutures Market Outlook to 2020
    Published: 15-Oct-2014        Price: US $2500 Onwards        Pages: 44
    GlobalData’s new report, ""Canada Surgical Sutures Market Outlook to 2020"", provides key market data on the Canada Surgical Sutures market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Automated Suturing Devices (Reusable and Disposable Automated Suturing Devices) and Sutures (Absorbable and .Non-Absorbable Sutures). The report also provides company shares and distribution shares data for each of these mar......
  • MediPoint: Aortic Stent Grafts – Global Analysis and Market Forecasts
    Published: 15-Oct-2014        Price: US $6495 Onwards        Pages: 260
    Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient’s native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated r......
  • Latest Guidebook for Conducting Medical Device Clinical Evaluation and Clinical Trial in China: From Regulations to Practices (2014 Edition)
    Published: 15-Oct-2014        Price: US $1495 Onwards        Pages: 199
    Summary China’s regulatory framework for medical devices is undergoing radical changes. The country’s new leaders have recognized that the regulations for supervision and administration of medical devices are far from perfect along with rapid population growth and thriving economy over the past 30 years. Chinese state council issued the latest “Regulations for the Supervision and Administration of Medical Devices” on February 12, 2014, which has come into force as of June 1, 2014. Bef......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs